LeMaitre Vascular to Participate at Canaccord Adams Inaugural Cardiovascular Conference

Thursday, November 8, 2007 General News
Email Print This Page Comment
Font : A-A+

BURLINGTON, Mass., Nov. 7 LeMaitre Vascular,Inc. (Nasdaq: LMAT), which develops, manufactures, and markets medical devicesand implants for the treatment of peripheral vascular disease, is scheduled toparticipate at the Canaccord Adams inaugural Cardiovascular Conference onTuesday, November 13, 2007, in New York City, NY at the Waldorf-Astoria Hotel.

David B. Roberts, President of LeMaitre Vascular, will provide an updateon the company at 3:45 pm Eastern Standard Time.

A live audio webcast of the presentation will be available via theInternet at http://www.lemaitre.com/investor and will be available for replayfor 30 days.

About LeMaitre Vascular

LeMaitre Vascular, Inc. develops, manufactures and markets medical devicesand implants for the treatment of peripheral vascular disease. The Company'sprincipal executive offices are located at 63 Second Avenue, Burlington,Massachusetts 01803. Additional information can be found athttp://www.lemaitre.com.

SOURCE LeMaitre Vascular, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook